Journal of Vaccine Research, 2025, Vol.15, No.1, 34-44 http://medscipublisher.com/index.php/jvr 44 Wang Y., Ling L., Jiang L., and Marín-López A., 2024, Research progress toward arthropod salivary protein vaccine development for vector-borne infectious diseases, PLOS Neglected Tropical Diseases, 18(12): e0012618. https://doi.org/10.1371/journal.pntd.0012618 Weaver S.C., Charlier C., Vasilakis N., and Lecuit M., 2018, Zika, chikungunya, and other emerging vector-borne viral diseases, Annual Review of Medicine, 69(1): 395-408. https://doi.org/10.1146/annurev-med-050715-105122 Weerarathna I.N., Doelakeh E.S., Kiwanuka L., Kumar P., and Arora S., 2024, Prophylactic and therapeutic vaccine development: advancements and challenges, Molecular Biomedicine, 5(1): 57. https://doi.org/10.1186/s43556-024-00222-x Zhang N.N., Li X., Deng Y., Zhao H., Huang Y., Yang G., Huang W., Gao P., Zhou C., Zhang R., Guo Y., Sun S., Fan H., Zu S., Chen Q., He Q., Cao T., Huang X., Qiu H., Nie J., Jiang Y., Yan H., Ye Q., Zhong X., Xue X., Zha Z., Zhou D., Yang X., Wang Y., Ying B., and Qin C., 2020, A thermostable mRNA vaccine against COVID-19, Cell, 182(5): 1271-1283. https://doi.org/10.1016/j.cell.2020.07.024 Zhang Y., 2024, Safety and efficacy of multi-pathogen vaccines: a comprehensive review, Journal of Vaccine Research, 14(5): 217-230. https://doi.org/10.5376/jvr.2024.14.0021
RkJQdWJsaXNoZXIy MjQ4ODYzNA==